MX9207344A - Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla. - Google Patents

Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.

Info

Publication number
MX9207344A
MX9207344A MX9207344A MX9207344A MX9207344A MX 9207344 A MX9207344 A MX 9207344A MX 9207344 A MX9207344 A MX 9207344A MX 9207344 A MX9207344 A MX 9207344A MX 9207344 A MX9207344 A MX 9207344A
Authority
MX
Mexico
Prior art keywords
penetration
hydrophobic
active agent
transdermic
improvers
Prior art date
Application number
MX9207344A
Other languages
English (en)
Inventor
Fun Soo Lee
Su Ti Yum
Michel J-N Cormier
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9207344A publication Critical patent/MX9207344A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Abstract

La presente invención se dirige a una novedosa formulación para utilizar efectivamente los aumentadores hidrofóbicos de penetración para la penetración incrementada de agentes activos a través de la pies o mucosa junto con reducción del tiempo de retardo entre las aplicaciones del agente activo y el logro de un flujo de agente terapéuticamente efectivo, con poca o ninguna irritación al huésped. La presente invención se dirige a composiciones que tienen un aumentador hidrofóbico de penetración, aumentador de penetración que ha sido micronizado y estabilizado en un vehículo inerte tal como agua. Estas composiciones pueden combinarse con el agente biológicamente activo para proveer una penetración aumentada del agente activo o la piel o mucosa.
MX9207344A 1991-12-16 1992-12-16 Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla. MX9207344A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80841191A 1991-12-16 1991-12-16
US84281692A 1992-02-27 1992-02-27

Publications (1)

Publication Number Publication Date
MX9207344A true MX9207344A (es) 1993-07-01

Family

ID=27123124

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207344A MX9207344A (es) 1991-12-16 1992-12-16 Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.

Country Status (3)

Country Link
AU (1) AU3326493A (es)
MX (1) MX9207344A (es)
WO (1) WO1993011798A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
AU6869996A (en) * 1995-09-13 1997-04-01 Morten Sloth Weidner Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
DE19732015C1 (de) * 1997-07-25 1998-07-23 Henkel Kgaa Selbstemulgierende Zubereitungen
FR2905601A1 (fr) * 2006-09-11 2008-03-14 Innoderm Sarl Utilisation de derives oleiques comme methode et composition favorisant la penetration cutanee des actifs contenus dans les compositions cosmetiques, pharmaceutiques ou dermatologiques.
WO2009143175A2 (en) * 2008-05-19 2009-11-26 Children's Medical Center Corporation Sensory-specific local anesthesia and prolonged duration local anesthesia
WO2009143174A2 (en) * 2008-05-19 2009-11-26 Children's Medical Center Corporation Chemical permeation enhancers enhance nerve blockade by toxins
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
PE20160011A1 (es) 2013-03-15 2016-02-10 Childrens Medical Center Formulaciones combinadas de neosaxitoxina para una anestesia local prolongada

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
YU2792A (sh) * 1991-01-19 1995-01-31 Hoechst A Ktiengesellschaft Disperzije finih čestica, antihelmintno efikasnih derivata, benzimidazola ili benztiazola ili pro-benzimidazola u vodi

Also Published As

Publication number Publication date
WO1993011798A1 (en) 1993-06-24
AU3326493A (en) 1993-07-19

Similar Documents

Publication Publication Date Title
ES2206714T3 (es) Composicion para el lavado de la piel.
UY24246A1 (es) Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
CO4940385A1 (es) Composiciones limpiadoras liquidas suaves antimicrobianas que se quitan enjuagando surfactantes acidos
DK302782A (da) Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden
US6676953B2 (en) Antifungal composition and method for human nails
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
BR9913154A (pt) Composição de musse
PE20010627A1 (es) Composiciones que tienen estabilidad mejorada
ES2143157T3 (es) Composicion estable que contiene acido ascorbico.
PE20000027A1 (es) Composiciones cosmeticas con dbs y siliconas funcionalizadas
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AR017779A1 (es) Formulaciones inyectables de larga actuacion y uso de la misma para la fabricacion de un preparado
PT1035844E (pt) Utilizacao de poliois no combate a infeccoes por leveduras e preparacoes de poliol para a referida utilizacao
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
MX9207344A (es) Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.
MX9400800A (es) Un complejo de estabilizacion neutro para ci-979 hci, un activador de la cognicion.
DK0535734T3 (da) Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
BRPI0418115A (pt) formulação lìquida estável de hormÈnio de crescimento
PE17397A1 (es) Compuesto trans-dermico en parche del 3-[4-(hexiloxi)-1,2,5-tiadiazol-3-il]-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina)
HN1999000135A (es) Formulacion liquida.
MX9400801A (es) Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon.
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
SE8101374L (sv) Kompositioner innehallande n,n-dietyl-m-toluamid
CO4960657A1 (es) Composicion farmaceutica